Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 43.46 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.47 | 1.09% | 43.46 | 43.75 | 42.94 | 43.61 | 42.99 | 17:59:58 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 36.68 | 88.60 | 51.92 | 58.60% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,393 | 332,664 | $ 43.44 | $ 14,450,536 | 590,973 | 38.62 - 85.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:48:51 | average | 9,571 | $ 43.46 | USD |
Agios Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.55B | 58.75M | $ -346.03M | -6.03 | - | 57.95M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Agios Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.12 | 44.14 | 41.8 | 42.7745 | 576k | 1.34 | 3.18% |
| 1 Month | 46.52 | 48.72 | 38.62 | 43.1105 | 576k | -3.06 | -6.58% |
| 3 Months | 47.3 | 53.43 | 38.62 | 46.3515 | 532k | -3.84 | -8.12% |
| 6 Months | 57.34 | 69.64 | 38.62 | 52.4108 | 515k | -13.88 | -24.21% |
| 1 Year | 75.87 | 85 | 38.62 | 56.5285 | 505k | -32.41 | -42.72% |
| 3 Years | 40.13 | 99.8242 | 35.84 | 58.9544 | 525k | 3.33 | 8.30% |
| 5 Years | 40.2 | 138.85 | 33.5 | 66.8035 | 588k | 3.26 | 8.11% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
